HomeConditionsChronic Graft Versus-Host Disease

Chronic Graft Versus-Host Disease

Chronic Graft Versus-Host Disease (cGVHD) is a complex condition that can occur after a stem cell or bone marrow transplant. It involves the transplanted cells attacking the recipient's tissues. Symptoms vary and can affect multiple organs. Diagnosis involves medical history, examination, and tests. Treatment aims to suppress the immune system using medications and supportive care. Prognosis varies, and long-term follow-up care is important. Prevention efforts focus on donor selection and compatibility testing. Overall,

Best medications for Chronic Graft Versus-Host Disease

Drug NameClassRouteStandard DosagePrice
ImbruvicaKinase InhibitorsOral420, 280, 140, 560, 70 MGfrom$17704.71
RezurockKinase InhibitorsOral200 MGfrom$18019.58


Chronic Graft Versus-Host Disease (cGVHD) is a medical condition that can occur after a stem cell or bone marrow transplant. It develops when the transplanted cells from a donor (graft) recognize the recipient's tissues (host) as foreign and attack them. cGVHD is a complex and potentially debilitating condition that affects various organs and systems in the body. It requires careful management and ongoing medical attention.


The symptoms of cGVHD can vary widely, depending on the organs and systems affected. Common symptoms include a rash, dry or itchy skin, joint pain, muscle weakness, fatigue, a dry mouth or eyes, difficulty swallowing, and gastrointestinal problems such as nausea, diarrhea, or abdominal pain. In more severe cases, cGVHD can lead to organ damage, compromising the lungs, liver, or other vital organs.


Diagnosing cGVHD is based on a combination of factors, including the patient's medical history, physical examination, and laboratory tests. Biopsies of affected tissues may be performed to confirm the diagnosis. It is important for healthcare providers to differentiate between acute graft-versus-host disease (aGVHD) and cGVHD, as they require different treatment approaches.


Managing cGVHD often involves a multi-disciplinary approach, with healthcare professionals from different specialties working together to provide comprehensive care. Treatment aims to suppress the immune system to reduce the severity of symptoms and prevent further organ damage. Medications such as corticosteroids, immunosuppressants, and targeted therapies may be prescribed. Additionally, supportive care measures may be implemented to address specific symptoms or complications.


The prognosis for cGVHD varies from person to person and depends on several factors, including the extent and severity of organ involvement, response to treatment, and overall health status. Some individuals may experience remission or improvement of symptoms over time, while others may face ongoing challenges and complications. Long-term follow-up care is crucial to monitor for potential complications and provide appropriate interventions.


Efforts to prevent cGVHD focus on careful donor selection and compatibility testing, as well as prophylactic medications given after the transplant to suppress the immune response. It is important for both the donor and recipient to be well-informed about the potential risks and benefits of the transplant procedure.


Chronic Graft Versus-Host Disease is a complex and challenging condition that can occur after a stem cell or bone marrow transplant. With proper management and ongoing medical care, many individuals with cGVHD can achieve symptom control and improve their quality of life. However, each case is unique, requiring individualized treatment plans and close monitoring by healthcare professionals.